The Loss of Expression of Caveolin-1 in Gastrointestinal Stromal Tumors
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : The down-regulation of caveolin-1, a putative tumor suppressor gene, has been demonstrated in several types of sarcomas. However, it''s not known whether or not the gastrointestinal stromal tumors (GISTs) express caveolin-1. We carried out this study to investigate the caveolin-1 expression in GISTs and to determine the correlation between the clinicopathologic profiles of GISTs and the expression of caveolin-1. Methods : One hundred eight cases of formalin-fixed and paraffin-embedded tissues of GISTs were immunohistochemically evaluated for the expression of caveolin-1 by using the tissue-array method. Survival data of 98 cases of primary GISTs was analysed according to the expression status of caveolin-1. Results : Ninety three cases (86.1%) of 108 GISTs did not express caveolin-1 protein. There was no correlation between the caveolin-1 expression status and any of the clinicopathologic variables, including mitosis (p=0.948) and tumor grade (p=0.334). The expression of caveolin-1 was not correlated with other immunohistochemical marker proteins including, c-kit (p=0.373), CD34 (p=0.437) and SMA (p=0.831). On the univariate analysis, the caveolin-1 expression status (p=0.635) was not a significant predictor of the disease-free survival for GIST patients. Conclusions : The results of this study suggest that caveolin-1 might act as a tumor suppressor gene in the GIST oncogenesis, but it has no function as a prognostic marker for disease free survival.
참고문헌 (30)
- Hamilton SR, "WHO Classification tumors of the digestive system International Agency for Research on Cancer Press", pp.9~143 (2000)
- Miettinen M, Monihan JM, Sarlomo-Rikala M, et al, "primary in the omentum and mesentery Clinicopathologic and immunohistochemical study of 26 cases", pp.1109~18
- Hirota S, "Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors", 279, pp.577~80 (1998)
- Fletcher CD, "Diagnosis of gastrointestinal stromal tumors:A consensus approach", 33, pp.459~65 (2002)
- "negative for KIT", immu(reactivity), pp.430~8
- Blay P, "Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias", 10, pp.4089~95 (2004), Clin Cancer Res
- Heinrich MC, "Biology and genetic aspects of gastrointestinal stromal tumors:KIT activation and cytogenetic alterations", 33, pp.484~95 (2002)
- Razani B, "Caveolin-1,a putative tumour suppressor gene", 29, pp.494~9 (2001)
- Engelman JA, "Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus that is frequently deleted in human cancers", pp.403~10
- Okamoto T, "Caveolins,a family of scaffolding proteins for organizing ‘‘preassembled signaling complexes’’ at the plasma membrane", 273, pp.5419~22 (1998)
- Koleske AJ, "Reduction of caveolin and caveolae in oncogenically transformed cells", 92, pp.1381~5 (1995)
- Wiechen K, "Down-regulation of caveolin-1,a candidate tumor suppressor gene,in sarcomas", 158, pp.833~9 (2001)
- Sircar K, "Interstitial cell of Cajal as precursors of gastrointestinal stromal tumors", 23, pp.377~89 (1999)
- Miettinen M, "Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117(KIT)", 13, pp.1134~42 (2000)
- Anderson RG, "A role for lipid shells in targeting proteins to caveolae,rafts,and other lipid domains", 296, pp.1821~5 (2002)
- Liu P, "Multiple functions of caveolin-1", 277, pp.41295~8 (2002)
- Koleske AJ, "Reduction of caveolin and caveolae in oncogenically transformed cells", 92, pp.1381~5 (1995)
- Galbiati F, "Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42", 44 MAP kinase cascade, 1998, pp.17, 6633~48
- Davidson B, "Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study", 81, pp.166~71 (2001)
- Cui J, "Hypermethylation of the caveolin-1 gene promoter in prostate cancer", 46, pp.249~56 (2001)
- Hayashi K, "Invasion activating caveolin-1 mutation in human scirrhous breast cancers", 61, pp.2361~4 (2001)
- Kato K, "Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage", 94, pp.929~33 (2002)
- Fine SW, "Elevated expression of caveolin-1 in adenocarcinoma of the colon", 115, pp.719~24 (2001)
- Ito Y, "Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid", 86, pp.912~6 (2002)
- Yang G, "Elevated expression of caveolin is associated with prostate and breast cancer", 4, pp.1873~80 (1998), Clin Cancer Res
- Rajjayabun PH, "Caveolin-1 expression is associated with high-grade bladder cancer", 58, pp.811~4 (2001)
- Park SH, "Ultrastructural studies of gastrointestinal stromal tumors", 19, pp.234~44 (2004)
- Rumessen JJ, "Ultrastructure of interstitial cells of Cajal in circular muscle of human small intestine", 104, pp.343~50 (1993)
- Eyden B, "Contribution of electron microscopy to understanding cellular differentiation in mesenchymal tumors of the gastrointestinal tract:a study of 82 tumors", 26, pp.269~85 (2002)
- Cho WJ, "Proteins of interstitial cells of Cajal and Intestinal smooth muscle,co-localized with caveolin-1", 288, pp.571~85 (2005)